You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

70 search results for: coexisting diseases

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma
Infographic

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

Pulmonology
Learn about the role of type 2 inflammation in the burden and pathophysiology of severe asthma in pediatric patients
View more
Emerging Perspectives on the Disease Burden and Management of Children With Atopic Dermatitis
expert video

Emerging Perspectives on the Disease Burden and Management of Children With Atopic Dermatitis

Dermatology
This video of the October 2024 ADVENT symposium at EAPS in Vienna, Austria features Drs Christine Bangert, Mark Boguniewicz, and Perla Lansang as they discuss the inflammatory processes driven by type 2 cytokines that lead to AD and atopic comorbidities, the multidimensional and cumulative disease burden associated with AD and its comorbidities, and the current and emerging treatment options for children with AD uncontrolled with topical therapy
View more
ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?
expert video

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Pulmonology
Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.
View more
La DA en pacientes pediátricos: Novedades en el abordaje terapéutico de la Dermatitis Atópica en niños a partir de 6 meses de edad
expert video

La DA en pacientes pediátricos: Novedades en el abordaje terapéutico de la Dermatitis Atópica en niños a partir de 6 meses de edad

Dermatology
En esta tercera escala de ADVENT ON TOUR en MADRID contamos con la Dra. Lucero Noguera, dermatóloga en el Hospital Infantil Universitario Niño Jesús nos presenta las novedades en el abordaje terapéutico de la dermatitis atópica pediátrica.
View more
La DA en pacientes pediátricos: Entendiendo la Dermatitis Atópica en la población infantil
expert video

La DA en pacientes pediátricos: Entendiendo la Dermatitis Atópica en la población infantil

Dermatology
En esta tercera escala de ADVENT ON TOUR en MADRID contamos con la Dra. Sara Palencia, dermatóloga en el Hospital Universitario 12 de Octubre, que nos habla sobre la dermatitis atópica en la población infantil.
View more
La DA en pacientes pediátricos: Experiencia con Dupilumab
expert video

La DA en pacientes pediátricos: Experiencia con Dupilumab

Dermatology
En esta tercera escala de ADVENT ON TOUR en MADRID contamos con la Dra. Marta Feito, dermatóloga en el Hospital Universitario La Paz, presentó su experiencia con Dupilumab.
View more
La DA en pacientes pediátricos: Debate y Discusión
expert video

La DA en pacientes pediátricos: Debate y Discusión

Dermatology
La DA en pacientes pediátricos: Debate y Discusión.
View more
PRURITO CRÓNICO: EL ORIGEN: DEBATE Y DISCUSIÓN
expert video

PRURITO CRÓNICO: EL ORIGEN: DEBATE Y DISCUSIÓN

Dermatology
No se pierda esta nueva escala de ADVENT ON TOUR desde Barcelona sobre prurito crónico.
View more
Origen y clínica del prurito
expert video

Origen y clínica del prurito

Dermatology
No se pierda esta nueva escala de ADVENT ON TOUR desde Barcelona sobre prurito crónico.
View more
Fisiopatología del prurito
expert video

Fisiopatología del prurito

Dermatology
No se pierda esta nueva escala de ADVENT ON TOUR desde Barcelona sobre prurito crónico.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: SpainChange country/region